New and Emerging Treatment Options for Refractory HER2 + Metastatic Breast Cancer. Expires on January 10, 2021 Eligible for Family Medicine, Oncology, Surgical Oncology, and Medical Critical Care Specialists. IPOKRATE team has selected this CME activity. Register, complete & earn CME credits...